Patent · US Active

Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants

US10894986B2 · kind B2 · utility

0Cited by
27References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 21, 2015
Grant dateJan 19, 2021
Priority date
Expiry dateAug 25, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/56
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention features diagnostic and therapeutic methods and compositions featuring androgen receptor variant proteins and nucleic acid molecules whose expression is increased in androgen related diseases or disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.